News

2GMED : Breaking Down Globus Medical: 5 Analysts Share Their Views
In the assessment of 12-month price targets, analysts unveil insights for Globus Medical, presenting an average target of $90.4, a high estimate of $103.00, and a low estimate of $80.00. This current ...
Globus Medical price target lowered to $80 from $82 at Truist
Truist lowered the firm’s price target on Globus Medical (GMED) to $80 from $82 and keeps a Hold rating on the shares as part of a broad ...
JMP Securities Reaffirms Their Hold Rating on Globus Medical (GMED)
JMP Securities analyst David Turkaly reiterated a Hold rating on Globus Medical (GMED – Research Report) today. The company’s shares opened ...
Medical Devices & Supplies - Specialty Stocks Q4 Teardown: Integer Holdings (NYSE:ITGR) Vs The Rest
Let’s dig into the relative performance of Integer Holdings (NYSE:ITGR) and its peers as we unravel the now-completed Q4 ...
GMED Stock May Benefit Following the Acquisition of Nevro
GMED recently completed its previously disclosed acquisition of Nevro Corp., a global medical device company that delivers ...